僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用 Olinvacimab （TTAC-0001） is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer